Nov 15 (Reuters) - PainReform Ltd PRFX.O :
* PAINREFORM PROVIDES BUSINESS UPDATE FOR THE THIRD QUARTER
OF
2022
* PAINREFORM - MAKING STEADY HEADWAY TOWARDS COMMENCING
PHASE 3
U.S. TRIAL OF PRF-110 FOR POST-OPERATIVE PAIN RELIEF FOLLOWING
BUNIONECTOMY SURGERY
* PAINREFORM LTD - ENCOUNTERED A REQUIREMENT FOR SOME
FURTHER WORK
THAT DELAYED START OF CLINICAL TRIAL
* PAINREFORM - BELIEVE ISSUE IS BEING RECTIFIED AND WE
EXPECT
STEPS WE ARE TAKING TO ULTIMATELY IMPROVE PRODUCT ITSELF, AS
WELL AS ITS MANUFACTURABILITY
* PAINREFORM LTD - PLAN TO COMMENCE OUR SECOND PHASE 3 TRIAL
FOR
PAIN TREATMENT IN HERNIA REPAIR SURGERY
Source text for Eikon: ID:nGNXZT63x
Further company coverage: PRFX.O